Top Markets
Coin of the day
InnoCan Pharma Corporation InnoCan Pharma Corporation

InnoCan Pharma Corporation

INNO
Classifica tra le azioni #33470
InnoCan Pharma Corporation is a pharmaceutical enterprise dedicated to... InnoCan Pharma Corporation is a pharmaceutical enterprise dedicated to innovating drug delivery systems that integrate cannabidiol (CBD) with other pharmaceutical compounds. Its operations and development efforts span across the United States, Poland, France, and various international markets. The company actively pursues research and development into treatments for conditions such as COVID-19, leveraging CBD delivered via exosomes and liposomes. InnoCan's product line features a range of CBD-infused topical items, including eye serum, face oil, face cream, facial serum, sleeping mask, recovery lotion, and the Relief & Go spray. Beyond R&D, the corporation is also involved in the marketing and distribution of its proprietary CBD-enhanced pharmaceutical and cosmetic offerings. Established in 2018, InnoCan Pharma Corporation maintains its principal office in Calgary, Canada.
Prezzo delle azioni
$1.69
Ultima sincronizzazione: 2026-08-13
Capitalizzazione di mercato
$7.59M
Variazione (1 giorno)
2.22%
Variazione (1 anno)
-84.04%
Paese
CA
Scambia InnoCan Pharma Corporation (INNO)

Categoria

Storico del rendimento da dividendi per InnoCan Pharma Corporation (INNO)
Il rendimento da dividendi (TTM) di InnoCan Pharma Corporation (simbolo azionario: INNO) al 2026 è: 0
Rendimento medio negli ultimi 5 anni: 0.00%
Storico del rendimento da dividendi per InnoCan Pharma Corporation (INNO) da 2026 a 2026
Rendimento da dividendi alla fine di ogni anno (TTM)
Anno Rendimento da dividendi Cambia
Non abbastanza dati per le date fornite.
Rendimenti da dividendi (TTM) di aziende simili o concorrenti